Bloomsbury Publishing (BMY) Competitors

GBX 615 +5.00 (+0.82%)

As of 04:59 AM Eastern

BMY vs. INDV, HCM, GRI, SLS, and ERGO

Should you buy Bloomsbury Publishing stock or one of its competitors? MarketBeat compares Bloomsbury Publishing with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bloomsbury Publishing include Indivior (INDV), HUTCHMED (HCM), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), and Ergomed (ERGO). These companies are all part of the "pharmaceutical products" industry.

How does Bloomsbury Publishing compare to Indivior?

Indivior (LON:INDV) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

Bloomsbury Publishing has lower revenue, but higher earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Indivior	£1.40B	1.38	-£2.36M	-£1.21	N/A
Bloomsbury Publishing	£340.70M	1.47	£37.37M	£27.40	22.45

86.0% of Indivior shares are held by institutional investors. Comparatively, 42.1% of Bloomsbury Publishing shares are held by institutional investors. 3.4% of Indivior shares are held by company insiders. Comparatively, 3.5% of Bloomsbury Publishing shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Bloomsbury Publishing has a consensus target price of GBX 820, suggesting a potential upside of 33.33%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, analysts plainly believe Bloomsbury Publishing is more favorable than Indivior.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Indivior	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Indivior has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.401, suggesting that its stock price is 60% less volatile than the broader market.

Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 1.2%. Bloomsbury Publishing pays an annual dividend of GBX 15.43 per share and has a dividend yield of 2.5%. Indivior pays out -1,243.7% of its earnings in the form of a dividend. Bloomsbury Publishing pays out 56.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, Indivior had 1 more articles in the media than Bloomsbury Publishing. MarketBeat recorded 1 mentions for Indivior and 0 mentions for Bloomsbury Publishing. Indivior's average media sentiment score of 0.30 beat Bloomsbury Publishing's score of 0.00 indicating that Indivior is being referred to more favorably in the media.

Company	Overall Sentiment
Indivior	Neutral
Bloomsbury Publishing	Neutral

Indivior has a net margin of 14.30% compared to Bloomsbury Publishing's net margin of 6.63%. Bloomsbury Publishing's return on equity of 10.70% beat Indivior's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Indivior	14.30%	-41.70%	2.37%
Bloomsbury Publishing	6.63%	10.70%	7.82%

Summary

Bloomsbury Publishing beats Indivior on 12 of the 18 factors compared between the two stocks.

How does Bloomsbury Publishing compare to HUTCHMED?

HUTCHMED (LON:HCM) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

Bloomsbury Publishing has a consensus price target of GBX 820, suggesting a potential upside of 33.33%. Given Bloomsbury Publishing's stronger consensus rating and higher possible upside, analysts plainly believe Bloomsbury Publishing is more favorable than HUTCHMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HUTCHMED	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

20.4% of HUTCHMED shares are held by institutional investors. Comparatively, 42.1% of Bloomsbury Publishing shares are held by institutional investors. 2.8% of HUTCHMED shares are held by company insiders. Comparatively, 3.5% of Bloomsbury Publishing shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Bloomsbury Publishing has lower revenue, but higher earnings than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HUTCHMED	£548.51M	2.92	-£52.98M	£53.00	3.52
Bloomsbury Publishing	£340.70M	1.47	£37.37M	£27.40	22.45

HUTCHMED has a beta of 0.453, meaning that its stock price is 55% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.401, meaning that its stock price is 60% less volatile than the broader market.

In the previous week, HUTCHMED had 1 more articles in the media than Bloomsbury Publishing. MarketBeat recorded 1 mentions for HUTCHMED and 0 mentions for Bloomsbury Publishing. Bloomsbury Publishing's average media sentiment score of 0.00 beat HUTCHMED's score of -1.05 indicating that Bloomsbury Publishing is being referred to more favorably in the news media.

Company	Overall Sentiment
HUTCHMED	Negative
Bloomsbury Publishing	Neutral

HUTCHMED has a net margin of 104.77% compared to Bloomsbury Publishing's net margin of 6.63%. HUTCHMED's return on equity of 41.38% beat Bloomsbury Publishing's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HUTCHMED	104.77%	41.38%	-5.90%
Bloomsbury Publishing	6.63%	10.70%	7.82%

Summary

Bloomsbury Publishing beats HUTCHMED on 9 of the 16 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Grainger?

Grainger (LON:GRI) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Grainger has a net margin of 77.24% compared to Bloomsbury Publishing's net margin of 6.63%. Bloomsbury Publishing's return on equity of 10.70% beat Grainger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Grainger	77.24%	10.25%	2.14%
Bloomsbury Publishing	6.63%	10.70%	7.82%

Grainger has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.401, meaning that its stock price is 60% less volatile than the broader market.

Bloomsbury Publishing has higher revenue and earnings than Grainger. Grainger is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Grainger	£258.90M	4.30	-£1.11M	£27.30	5.51
Bloomsbury Publishing	£340.70M	1.47	£37.37M	£27.40	22.45

Grainger currently has a consensus price target of GBX 252, suggesting a potential upside of 67.44%. Bloomsbury Publishing has a consensus price target of GBX 820, suggesting a potential upside of 33.33%. Given Grainger's higher possible upside, equities research analysts clearly believe Grainger is more favorable than Bloomsbury Publishing.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Grainger	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

48.3% of Grainger shares are owned by institutional investors. Comparatively, 42.1% of Bloomsbury Publishing shares are owned by institutional investors. 1.5% of Grainger shares are owned by company insiders. Comparatively, 3.5% of Bloomsbury Publishing shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Grainger had 5 more articles in the media than Bloomsbury Publishing. MarketBeat recorded 5 mentions for Grainger and 0 mentions for Bloomsbury Publishing. Grainger's average media sentiment score of 0.75 beat Bloomsbury Publishing's score of 0.00 indicating that Grainger is being referred to more favorably in the media.

Company	Overall Sentiment
Grainger	Positive
Bloomsbury Publishing	Neutral

Grainger pays an annual dividend of GBX 7.86 per share and has a dividend yield of 5.2%. Bloomsbury Publishing pays an annual dividend of GBX 15.43 per share and has a dividend yield of 2.5%. Grainger pays out 28.8% of its earnings in the form of a dividend. Bloomsbury Publishing pays out 56.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Grainger is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Grainger beats Bloomsbury Publishing on 10 of the 18 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Standard Life UK Smaller Companies Trust?

Standard Life UK Smaller Companies Trust (LON:SLS) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

In the previous week, Standard Life UK Smaller Companies Trust's average media sentiment score of 0.00 equaled Bloomsbury Publishing'saverage media sentiment score.

Company	Overall Sentiment
Standard Life UK Smaller Companies Trust	Neutral
Bloomsbury Publishing	Neutral

42.1% of Bloomsbury Publishing shares are owned by institutional investors. 3.5% of Bloomsbury Publishing shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Bloomsbury Publishing has a net margin of 6.63% compared to Standard Life UK Smaller Companies Trust's net margin of 0.00%. Bloomsbury Publishing's return on equity of 10.70% beat Standard Life UK Smaller Companies Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Standard Life UK Smaller Companies Trust	N/A	N/A	N/A
Bloomsbury Publishing	6.63%	10.70%	7.82%

Standard Life UK Smaller Companies Trust pays an annual dividend of GBX 0.08 per share. Bloomsbury Publishing pays an annual dividend of GBX 15.43 per share and has a dividend yield of 2.5%. Standard Life UK Smaller Companies Trust pays out 0.0% of its earnings in the form of a dividend. Bloomsbury Publishing pays out 56.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Bloomsbury Publishing has higher revenue and earnings than Standard Life UK Smaller Companies Trust. Standard Life UK Smaller Companies Trust is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Standard Life UK Smaller Companies Trust	£222.48M	0.00	N/A	£217.40	N/A
Bloomsbury Publishing	£340.70M	1.47	£37.37M	£27.40	22.45

Bloomsbury Publishing has a consensus price target of GBX 820, suggesting a potential upside of 33.33%. Given Bloomsbury Publishing's stronger consensus rating and higher possible upside, analysts clearly believe Bloomsbury Publishing is more favorable than Standard Life UK Smaller Companies Trust.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Standard Life UK Smaller Companies Trust	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Bloomsbury Publishing beats Standard Life UK Smaller Companies Trust on 11 of the 13 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Ergomed?

Ergomed (LON:ERGO) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

In the previous week, Ergomed's average media sentiment score of 0.00 equaled Bloomsbury Publishing'saverage media sentiment score.

Company	Overall Sentiment
Ergomed	Neutral
Bloomsbury Publishing	Neutral

71.1% of Ergomed shares are owned by institutional investors. Comparatively, 42.1% of Bloomsbury Publishing shares are owned by institutional investors. 18.2% of Ergomed shares are owned by insiders. Comparatively, 3.5% of Bloomsbury Publishing shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Ergomed has a net margin of 9.87% compared to Bloomsbury Publishing's net margin of 6.63%. Ergomed's return on equity of 18.08% beat Bloomsbury Publishing's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ergomed	9.87%	18.08%	10.16%
Bloomsbury Publishing	6.63%	10.70%	7.82%

Ergomed has a beta of 0.79, indicating that its stock price is 21% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.401, indicating that its stock price is 60% less volatile than the broader market.

Bloomsbury Publishing has higher revenue and earnings than Ergomed. Ergomed is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ergomed	£152.09M	0.00	£15M	£0.29	N/A
Bloomsbury Publishing	£340.70M	1.47	£37.37M	£27.40	22.45

Bloomsbury Publishing has a consensus price target of GBX 820, suggesting a potential upside of 33.33%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, analysts clearly believe Bloomsbury Publishing is more favorable than Ergomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ergomed	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Ergomed beats Bloomsbury Publishing on 7 of the 13 factors compared between the two stocks.

Get Bloomsbury Publishing News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BMY vs. The Competition

Export

Metric	Bloomsbury Publishing	Publishing Industry	Communication Sector	LON Exchange
Market Cap	£500.59M	£1.20B	£3.35B	£2.78B
Dividend Yield	2.58%	9.08%	6.82%	6.09%
P/E Ratio	22.45	49.90	14.14	365.92
Price / Sales	1.47	53.63	115.98	88,371.87
Price / Cash	8.91	15.71	15.98	27.89
Price / Book	2.47	1.18	4.68	7.70
Net Income	£37.37M	£59.19M	£125.80M	£5.89B
7 Day Performance	-0.81%	-0.77%	0.46%	0.48%
1 Month Performance	5.32%	-1.52%	7.51%	2.53%
1 Year Performance	-1.44%	-8.74%	13.98%	87.11%

Bloomsbury Publishing Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BMY Bloomsbury Publishing	2.2515 of 5 stars	GBX 615 +0.8%	GBX 820 +33.3%	-2.9%	£500.59M	£340.70M	22.45	34,300
INDV Indivior	N/A	GBX 1,238 +1.6%	N/A	+46.3%	£1.93B	£1.40B	N/A	1,000	Gap Up High Trading Volume
HCM HUTCHMED	N/A	GBX 193.10 -2.5%	N/A	-10.7%	£1.66B	£548.51M	3.64	1,760
GRI Grainger	4.2861 of 5 stars	GBX 163.20 -1.0%	GBX 252 +54.4%	-27.1%	£1.21B	£258.90M	5.98	372
SLS Standard Life UK Smaller Companies Trust	N/A	N/A	N/A	N/A	£715.41M	£222.48M	3.37	10

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:BMY) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bloomsbury Publishing (BMY) Competitors

BMY vs. INDV, HCM, GRI, SLS, and ERGO

How does Bloomsbury Publishing compare to Indivior?

Summary

How does Bloomsbury Publishing compare to HUTCHMED?

Summary

How does Bloomsbury Publishing compare to Grainger?

Summary

How does Bloomsbury Publishing compare to Standard Life UK Smaller Companies Trust?

Summary

How does Bloomsbury Publishing compare to Ergomed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMY vs. The Competition

Bloomsbury Publishing Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bloomsbury Publishing (BMY) Competitors

BMY vs. INDV, HCM, GRI, SLS, and ERGO

How does Bloomsbury Publishing compare to Indivior?

Which has preferable valuation and earnings, INDV or BMY?

Do insiders & institutionals have more ownership in INDV or BMY?

Do analysts recommend INDV or BMY?

Which has more risk and volatility, INDV or BMY?

Is INDV or BMY a better dividend stock?

Does the media refer more to INDV or BMY?

Is INDV or BMY more profitable?

Summary

How does Bloomsbury Publishing compare to HUTCHMED?

Do analysts rate HCM or BMY?

Do institutionals & insiders hold more shares of HCM or BMY?

Which has preferable earnings & valuation, HCM or BMY?

Which has more volatility and risk, HCM or BMY?

Does the media favor HCM or BMY?

Is HCM or BMY more profitable?

Summary

How does Bloomsbury Publishing compare to Grainger?

Is GRI or BMY more profitable?

Which has more volatility and risk, GRI or BMY?

Which has better earnings and valuation, GRI or BMY?

Do analysts recommend GRI or BMY?

Do insiders and institutionals believe in GRI or BMY?

Does the media favor GRI or BMY?

Is GRI or BMY a better dividend stock?

Summary

How does Bloomsbury Publishing compare to Standard Life UK Smaller Companies Trust?

Does the media refer more to SLS or BMY?

Do insiders and institutionals believe in SLS or BMY?

Is SLS or BMY more profitable?

Is SLS or BMY a better dividend stock?

Which has better earnings and valuation, SLS or BMY?

Do analysts recommend SLS or BMY?

Summary

How does Bloomsbury Publishing compare to Ergomed?

Does the media refer more to ERGO or BMY?

Do institutionals and insiders hold more shares of ERGO or BMY?

Is ERGO or BMY more profitable?

Which has more volatility & risk, ERGO or BMY?

Which has stronger earnings & valuation, ERGO or BMY?

Do analysts recommend ERGO or BMY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMY vs. The Competition

Bloomsbury Publishing Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools